At the same time, loss-of-function mutations in either Tsc1 or Tsc2 genes, which are direct intracellular inhibitors of mTORC1, cause a genetic disorder named Tuberous Sclerosis Complex (TSC), characterized by the growth of benign tumors in multiple areas. Here, TSC2 is linked to hereditary disease.